Analysts Set Haleon PLC Sponsored ADR (NYSE:HLN) PT at $12.33

Key Points

• Haleon PLC Sponsored ADR (NYSE:HLN) has received a consensus rating of "Moderate Buy" from analysts, with four hold ratings, three buy ratings, and two strong buy ratings.
• The company's average 12-month price target is $12.3250, with significant upgrades from analysts including BNP Paribas and Barclays.
• Haleon recently announced an increase in its semi-annual dividend to $0.0555, marking a yield of 190.0%, up from the previous $0.05.

Haleon PLC Sponsored ADR (NYSE:HLN - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the nine ratings firms that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating, three have given a buy rating and two have given a strong buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $12.3250.

A number of equities analysts recently issued reports on HLN shares. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a report on Tuesday, May 27th. Wall Street Zen cut Haleon from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. BNP Paribas Exane upgraded shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 target price on the stock in a report on Tuesday, May 27th. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target for the company in a report on Friday, May 9th. Finally, Barclays reiterated an "overweight" rating on shares of Haleon in a report on Tuesday, May 6th.

Haleon Stock Performance

Shares of NYSE HLN traded up $0.08 during midday trading on Friday, hitting $9.77. 536,090 shares of the stock traded hands, compared to its average volume of 12,673,697. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87. Haleon has a one year low of $8.86 and a one year high of $11.42. The firm has a market capitalization of $43.79 billion, a P/E ratio of 25.01, a PEG ratio of 2.87 and a beta of 0.23. The firm has a 50-day moving average of $9.86 and a two-hundred day moving average of $10.21.

Haleon Increases Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 18th. Shareholders of record on Friday, August 15th will be given a $0.0555 dividend. This is a boost from Haleon's previous semi-annual dividend of $0.05. The ex-dividend date of this dividend is Friday, August 15th. This represents a yield of 190.0%. Haleon's dividend payout ratio is currently 28.21%.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. Hanson & Doremus Investment Management lifted its holdings in shares of Haleon by 234.1% in the 2nd quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company's stock worth $25,000 after buying an additional 1,662 shares during the period. Bartlett & CO. Wealth Management LLC raised its holdings in shares of Haleon by 135.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock valued at $27,000 after purchasing an additional 1,491 shares in the last quarter. Banque Transatlantique SA purchased a new stake in shares of Haleon in the 1st quarter worth approximately $27,000. Golden State Wealth Management LLC boosted its position in Haleon by 107.6% during the 2nd quarter. Golden State Wealth Management LLC now owns 2,721 shares of the company's stock valued at $28,000 after acquiring an additional 1,410 shares in the last quarter. Finally, Opal Wealth Advisors LLC bought a new stake in shares of Haleon in the 1st quarter valued at about $29,000. Hedge funds and other institutional investors own 6.67% of the company's stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.